Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

​​Changes to medical policy on insertion of implantable infusion pumps

December 22, 2022

​Effective January 16, 2023, Independence Blue Cross and Independence Administrators will update their medical policy on insertion of implantable infusion pumps for Commercial and Medicare Advantage members.

For Commercial members, medically necessary criteria will be updated for the treatment of chemotherapy for cancer and for opioid drugs for chronic intractable pain.

For Medicare Advantage members, medically necessary criteria will be updated for administration of continuous subcutaneous insulin for the treatment of diabetes mellitus. Not medically necessary criteria will be added for external infusion pump and related drugs and supplies in the home setting for the treatment of thromboembolic disease and/or pulmonary embolism by heparin infusion.

For more information, view the notifications for the following policies, which were published on December 16, 2022, and December 19, 2022:


This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.